Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 13.81% vs 78.37% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 6.54% vs 601.56% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 8.98% vs 2,475.00% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -52.63% vs -39.68% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of ADMA Biologics, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 6.27% vs -2.30% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 13.81% vs 78.37% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 27.14% vs -75.96% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 6.54% vs 601.56% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 21.68% vs -8.44% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 8.98% vs 2,475.00% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -10.00% vs -31.03% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -52.63% vs -39.68% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






